169 related articles for article (PubMed ID: 30417279)
21. LITFULO
Gupta AK; Ravi SP; Vincent K; Abramovits W
Skinmed; 2023; 21(6):434-438. PubMed ID: 38051245
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis.
Yan T; Wang T; Tang M; Liu N
Front Pharmacol; 2024; 15():1372810. PubMed ID: 38659584
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis.
Lee YY; Lim HH; Son S; Jin S; Shin JM; Hong DK; Jung KE; Seo YJ; Lee TK; Kim YM; Lee Y
Clin Exp Dermatol; 2024 Mar; ():. PubMed ID: 38501938
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the sources and types of dietary and nutritional advice for patients with alopecia areata.
Yan A; Drake L; Hadsall S; Gaurav A; Xia E; Mostaghimi A
Arch Dermatol Res; 2024 May; 316(6):283. PubMed ID: 38796551
[TBL] [Abstract][Full Text] [Related]
25. A cross-sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system.
Ravipati A; Pradeep T; Tosti A
Int J Dermatol; 2024 Apr; 63(4):497-502. PubMed ID: 38217053
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study.
Rinaldi F; Trink A; Pinto D
Dermatol Ther (Heidelb); 2020 Jun; 10(3):483-493. PubMed ID: 32279227
[TBL] [Abstract][Full Text] [Related]
27. Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib.
Tang GT; Triwongwaranat D; Sinclair R; Joseph S; Eisman S; Rathnayake D; Varathan V; Trindade de Carvalho L; Bhoyrul B
Clin Exp Dermatol; 2024 Jan; ():. PubMed ID: 38270233
[TBL] [Abstract][Full Text] [Related]
28. Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases.
Schett G; Sloan VS; Stevens RM; Schafer P
Ther Adv Musculoskelet Dis; 2010 Oct; 2(5):271-8. PubMed ID: 22870453
[TBL] [Abstract][Full Text] [Related]
29. Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey.
Nakamura K; Kamei K; Austin J; Marwaha S; Piercy J; Anderson P; Sakaki-Yumoto M; Ohyama M
Dermatol Ther (Heidelb); 2024 Jan; 14(1):151-167. PubMed ID: 38079099
[TBL] [Abstract][Full Text] [Related]
30. Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study.
Zhou J; Yang Y; Xu M; Lyu Z; Wu X
Clin Cosmet Investig Dermatol; 2023; 16():2947-2956. PubMed ID: 37873509
[TBL] [Abstract][Full Text] [Related]
31. An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review.
Xia E; Li SJ; Drake L; Reyes-Hadsall S; Mita C; Drucker AM; Mostaghimi A
J Invest Dermatol; 2023 Jul; 143(7):1133-1137.e12. PubMed ID: 37115113
[TBL] [Abstract][Full Text] [Related]
32. Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel.
Rudnicka L; Trzeciak M; Alpsoy E; Arenberger P; Alper S; Benáková N; Bobko S; Borlu M; Czarnecka Operacz M; Engin B; Ergun T; Sağduyu IE; Filipovská O; Gadzhigoroeva A; Kojanová M; Lesiak A; Michenko A; Murashkin N; Onsun N; Owczarek W; Plzakova Z; Reich A; Selerová M; Gürbüz BA
Front Med (Lausanne); 2024; 11():1353354. PubMed ID: 38741770
[TBL] [Abstract][Full Text] [Related]
33. Two-dimensional planimetry for alopecia areata severity evaluation compared with severity of alopecia tool: A pilot study.
Seol JE; Hong SM; Ahn SW; Jang SH; Kim H
Skin Res Technol; 2023 Sep; 29(9):e13440. PubMed ID: 37753671
[TBL] [Abstract][Full Text] [Related]
34. Investigation of oxidative stress in patients with alopecia areata by measuring the levels of malondialdehyde and ceruloplasmin in the blood.
Cwynar A; Olszewska-Słonina D; Czajkowski R; Zegarska B; Białecka A; Męcińska-Jundziłł K; Piskorska E; Lampka M
Postepy Dermatol Alergol; 2018 Dec; 35(6):572-576. PubMed ID: 30618523
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023).
Fatani MIA; Alkhalifah A; Alruwaili AFS; Alharbi AHS; Alharithy R; Khardaly AM; Almudaiheem HY; Al-Jedai A; Eshmawi MTY
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2129-2151. PubMed ID: 37558830
[TBL] [Abstract][Full Text] [Related]
36. The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms.
Blednov YA; Shawlot W; Homanics GE; Osterndorff-Kahanek EA; Mason S; Mayfield J; Smalley JL; Moss SJ; Messing RO
Neuropharmacology; 2024 Jun; ():110035. PubMed ID: 38876310
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan's National Health Insurance Research Database.
Tsai TF; Huang YH; Wei CY; Ng KJ; Newson RS; Lee TH; Shen D; Wang BCM; Tang CH
Value Health Reg Issues; 2024 Jun; 43():101007. PubMed ID: 38865765
[TBL] [Abstract][Full Text] [Related]
38. Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T; Okubo Y; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Uehara N; Handa T; Tanaka M; Zhang W; Paris M; Murakami M
Am J Clin Dermatol; 2024 Jan; 25(1):165-167. PubMed ID: 38060175
[No Abstract] [Full Text] [Related]
39. Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients.
Vivian A; Carvalho VO; Kiszewski AE
An Bras Dermatol; 2023; 98(6):837-840. PubMed ID: 37407332
[No Abstract] [Full Text] [Related]
40. Ineffectiveness of apremilast in moderate-to-severe pemphigus: A case series of three patients.
Zhang Q; Yu L; Wan L; Chen L; Chen J
Australas J Dermatol; 2024 May; ():. PubMed ID: 38783774
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
